Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Brief Summary: This study tested whether taking a pill of tenofovir and emtricitabine (two antiretroviral medicines) was safe for sexually-active young adults in Botswana without HIV infection and whether it reduced their risk of getting an HIV infection.


Options:
A: Arm Label: Tenofovir Disoproxil Fumarate (TDF); Type: ACTIVE_COMPARATOR; Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF) | Arm Label: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF); Type: ACTIVE_COMPARATOR; Interventions: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tenofovir Disoproxil Fumarate (TDF); Assigned to Arm(s): Tenofovir Disoproxil Fumarate (TDF) | Intervention Type: DRUG; Name: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF); Assigned to Arm(s): Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: TDF-FTC,condoms,adh/risk counseling; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg | Arm Label: Placebo,condoms,adh/risk counseling; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg; Assigned to Arm(s): TDF-FTC,condoms,adh/risk counseling | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo,condoms,adh/risk counseling
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Atazanavir, Drug: Didanosine, Drug: Efavirenz, Drug: Emtricitabine/Tenofovir disoproxil fumarate, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine, Drug: Tenofovir disoproxil fumarate, Drug: Zidovudine/Lamivudine | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Atazanavir, Drug: Didanosine, Drug: Efavirenz, Drug: Emtricitabine/Tenofovir disoproxil fumarate, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine, Drug: Tenofovir disoproxil fumarate, Drug: Zidovudine/Lamivudine | Intervention Type: DRUG; Name: Atazanavir; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Didanosine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Emtricitabine/Tenofovir disoproxil fumarate; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Lamivudine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Stavudine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Tenofovir disoproxil fumarate; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Zidovudine/Lamivudine; Assigned to Arm(s): 1, 2
D: Arm Label: Truvada Arm; Type: EXPERIMENTAL; Interventions: Drug: Truvada | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Truvada; Assigned to Arm(s): Truvada Arm | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo Arm

Answer: B